(Philadelphia,
PA) -- Dwight L. Evans, MD, Chair of Psychiatry
at the University of Pennsylvania School of Medicine
and Professor of Psychiatry, Medicine, and Neuroscience,
has been named a member of the Board of Scientific Counselors
of the National Institutes of Mental Health (NIMH),
an honor and responsibility reserved for the nation's
most prominent researchers.
Members of the Board of Scientific Counselors are responsible
for reviewing and assessing the quality of laboratory
and clinical studies conducted by the NIH, as part of
its Intramural Research Program. Their responsibilities
include providing advice for the scientific direction,
administration and long-term goals of each research
project; assessing the progress of each project's lead
investigator; and making recommendations regarding the
allocation of federal research funds.
Evans completed his residency and fellowship programs
at the University of North Carolina where he rose to
Professor of Psychiatry and Medicine and Associate Director
of the NIMH Clinical Research Center. He then moved
to the University of Florida where he served as Chair
of Psychiatry and Professor of Psychiatry, Medicine,
and Neuroscience. He is known internationally for his
research on the neurobiology and treatment of depression.
He is a frequent consultant to NIMH and served as Chair
of the AIDS/Immunology Research Review Committee.
Evans joined the University of Pennsylvania School of
Medicine in 1997 as Professor and Chair of the Department
of Psychiatry. Under his leadership, the Department
has risen to number two nationally among all departments
of psychiatry for NIH research funding.
The education and training programs have national prominence,
and the clinical programs at HUP are ranked number one
for best and preferred Delaware Valley Hospitals for
psychiatry, in Pennsylvania and New Jersey. In addition,
psychiatry is one of the 15 medical specialties which
were selected for exceptional performance, leading to
HUP's designation as an honor roll hospital by U.S.
News & World Report.
# # #
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.